Busy. Please wait.
or

show password
Forgot Password?

Don't have an account?  Sign up 
or

Username is available taken
show password

why


Make sure to remember your password. If you forget it there is no way for StudyStack to send you a reset link. You would need to create a new account.
We do not share your email address with others. It is only used to allow you to reset your password. For details read our Privacy Policy and Terms of Service.


Already a StudyStack user? Log In

Reset Password
Enter the associated with your account, and we'll email you a link to reset your password.

Remove Ads
Don't know
Know
remaining cards
Save
0:01
To flip the current card, click it or press the Spacebar key.  To move the current card to one of the three colored boxes, click on the box.  You may also press the UP ARROW key to move the card to the "Know" box, the DOWN ARROW key to move the card to the "Don't know" box, or the RIGHT ARROW key to move the card to the Remaining box.  You may also click on the card displayed in any of the three boxes to bring that card back to the center.

Pass complete!

"Know" box contains:
Time elapsed:
Retries:
restart all cards




share
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.

  Normal Size     Small Size show me how

59 60 61 62 63 drugs

paramedic drugs

QuestionAnswer
Description: this is an injectable NSAID that exhibits analgesic, anti-inflammatory, and antipyretic properties without sedative effects KETOROLAC
Indications: mild or moderate pain KETOROLAC
Contraindications: hypersensitivity to ketorolac, aspirin, or other NSAIDs; asthma KETOROLAC
Precautions: peptic ulcers, renal or hepatic impairment, elderly KETOROLAC
Dosage/Route: 30 mg IV/IM (15 mg >65 years or weighs <50kg) KETOROLAC
Description: this is a beta blocker with some alpha blocker characteristics. it induces vasodilation, reduces peripheral vascular resistance, and lowers blood pressure LABETALOL
Indications: acute hypertensive crisis LABETALOL
Contraindications: asthma, CHF, 2nd-3rd degree heart block, severe bradycardia, cardiogenic shock LABETALOL
Precautions: COPD, heart failure, hepatic impairment, diabetes, peripheral vascular disease LABETALOL
Dosage/Route: 10 mg slow IV, then 20-40 mg/10 min as needed, up to 150 mg or a bolus of 10 mg, then continuous drip of 2-8 mg/min LABETALOL
Description: this is an antidysrhythmic that suppresses automaticity and raises stimulation threshold of the ventricles. it also causes sedation, anticonvulsant, and analgesic effects LIDOCAINE
Indications: pulseless ventricular tachycardia, ventricular fibrillation, ventricular tachycardia (w/pulse) LIDOCAINE
Contraindications: hypersensitivity to amide-type local anesthetics, supraventricular dysrhythmias, strokes-adams syndrome, 2nd and 3rd degree heart block, bradycardias LIDOCAINE
Precautions: hepatic or renal impairment, CHF, hypoxia, respiratory depression, hypovolemia, myasthenia gravis, shock, devilitated patients, elderly, family history of malignant hypothermia LIDOCAINE
Dosage/Route: cardiac arrest: 1-1.5 mg/kg IV/IO repeated at .5-.75 every 5-10 min up to 3 mg/kg, follow conversion with a drip of 1-4 mg/min. Ped: 1 mg/kg IV/IO, to 100mg, follow conversion with a drip of 20-50 mcg/kg/min LIDOCAINE
Dosage/Route: Ventricular Tachycardia (w/pulse): .5-1.5 mg/kg slow IV/IO. May repeat at one-half dose every 5-10 min until conversion up to 3 mg/kg. follow conversion with an infusion of 1-4mg/min. Ped: 1mg/kg IV/IO, followed by a drip at 20-50mcg/kg/min LIDOCAINE
Description: this is the most potent benzodiazepine available. it has strong antianxiety, sedative, hypnotic, and skeletal muscle relaxant properties, and a relatively short half-life LORAZEPAM
Indications: sedation for cardioversion and status epilepticus LORAZEPAM
Contraindications: sensitivity to benzodiazepines LORAZEPAM
Precautions: narrow-angle glaucoma, depression or psychosis, coma, shock, acute alcohol intoxication, renal or hepatic impairment, organic brain syndrome, myasthenia gravis, GI disorders, elderly, devilitated, limited pulmonary reserve LORAZEPAM
Dosage/Route: Sedation: 1-4 mg IM, .5-2 mg IV. Ped: .03-.5 mg/kg IV/IM/PR up to 4mg. Status Epilepticus: 2mg slow IV/PR (2mg/min). ped: .1 mg/kg slow IV/PR (2-5min) LORAZEPAM
Description: this is an electrolyte that acts as a calcium channel blocker, acting as a CNS depressant and anticonvulsant. it also depresses the function of smooth, skeletal, and cardiac muscles MAGNESIUM SULFATE
Indications: torsade de pointes, eclamptic seizures. in children for status asthmaticus nonresponsive to beta agents MAGNESIUM SULFATE
Contraindications: heart block, myocardial damage, shock, persistent hypertension, hypocalcemia MAGNESIUM SULFATE
Precautions: renal impairment, digitalized patients, other CNS depressants, neuromuscular blocking agents MAGNESIUM SULFATE
Dosage/Route: Cardiac Arrest: 1-2 g d diluted in 10 mL of D5W IV/IO. Ped: 25-50 mg/kg IV/IO, max dose 2g MAGNESIUM SULFATE
Dosage/Route: Torsades: 1-2g diluted in 50-100mL of D5W over 5-60 min. follow with .5-1g per hour IV titrated to effect Ped: 25-50 mg/kg IV/IO (max dose 2g) over 15-20 min MAGNESIUM SULFATE
Dosage/Route: Status Asthmaticus (pediatric only): 25-50 mg/kg IV/IO over 15-30 min. max dose 2g. Eclampsia: 2-4g IV/IM MAGNESIUM SULFATE
Created by: rubtuge